According to a new report, published by KBV research, The Global Clinical Risk Grouping Solution Market size is expected to reach $1.7 billion by 2031, rising at a market growth of 12.9% CAGR during the forecast period.
The Software segment is leading the Global Clinical Risk Grouping Solution Market by Product in 2023; thereby, achieving a market value of $1.2 billion by 2031. This dominance is due to the growing dependence on advanced data analytics and artificial intelligence (AI) tools that are integrated into the software to accurately stratify patient risk, a function that is indispensable in contemporary healthcare environments. The growing adoption of value-based care models and the shift towards personalized medicine has fueled demand for sophisticated software solutions that enable healthcare providers to manage patient populations more effectively.
The Ambulatory Surgical Centers segment is anticipating a CAGR of 13.4% during (2024 - 2031). Ambulatory surgical centers (ASCs) that specialize in outpatient surgical care have progressively acknowledged the importance of clinical risk grouping solutions in enhancing surgical outcomes and ensuring patient safety. By utilizing these solutions, ASCs can better assess the risk profiles of patients undergoing surgery, enabling more personalized care and reducing the likelihood of complications or readmissions. The growth of this segment in the market has been further bolstered by the increasing emphasis on cost-effective and high-quality care in ambulatory settings.
The Private Cloud segment is generating higher revenue share in the Global Clinical Risk Grouping Solution Market by Deployment in 2023; thereby, achieving a market value of $938 million by 2031. This prominence is largely due to the heightened demand for data security and compliance with stringent healthcare regulations, such as HIPAA in the United States and GDPR in Europe. Private cloud deployments offer healthcare organizations greater control over their data environments, ensuring that sensitive patient information is securely managed and stored.
The Chronic Disease Management segment is registering a CAGR of 12.5% during (2024 - 2031). The necessity for effective management strategies that can enhance patient outcomes and decrease healthcare costs has been exacerbated by the increasing prevalence of chronic conditions, including diabetes, heart disease, and respiratory ailments. Clinical risk grouping solutions are crucial in this area, as they enable healthcare providers to identify patients at higher risk of complications, personalize care plans, and monitor disease progression more effectively.
Full Report: https://www.kbvresearch.com/clinical-risk-grouping-solution-market/
The North America region dominated the Global Clinical Risk Grouping Solution Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $682.3 million by 2031. The Europe region is experiencing a CAGR of 12.7% during (2024 - 2031). Additionally, The Asia Pacific region would exhibit a CAGR of 13.6% during (2024 - 2031).
By Product
By End-use
By Deployment
By Application
By Geography
Unique Offerings 
